Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 15551 - 15575 of 15589 in total
ETC-1001 is Pfizer’s lead oral small molecule product candidate which is intended to be a chronic treatment for individuals with lipid disorders.
Investigational
Experimental
Experimental
AEOL 10150 is developed by Aeolus as a therapeutic agents based on its proprietary small molecule catalytic antioxidants.
Investigational
Experimental
Tozadenant has been investigated for the basic science of Cocaine Dependence.
Investigational
Experimental
Experimental
Displaying drugs 15551 - 15575 of 15589 in total